undamentalytics Newsletter
Sign in

Teladoc Health, Inc. revenue

Teladoc Health, Inc.'s revenue was $2.53bn in fiscal 2025, down 1.5% on the year before. Since fiscal 2013 ($19.9m) it has grown at a compound 49.7% a year. Over the last twelve months it was $2.47bn.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2013Dec 20132014Dec 20142015Dec 20152016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue2044771232334185531,0942,0332,4072,6022,5702,5302,468
Growth on the year before—+118.7%+77.8%+59.2%+89.4%+79.1%+32.4%+97.7%+85.8%+18.4%+8.1%−1.3%−1.5%—
Gross profit163456911722893697031,3821,663————

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Access Fees Revenue $2.1B 82.7% ▼ 5.6%
Other $438M 17.3% ▲ 23.6%
Geography
Region Revenue Share YoY
United States $2.1B 81.9% ▼ 4.1%
Outside the US $458M 18.1% ▲ 11.9%

From Teladoc Health, Inc.'s 10-K filed February 26, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Technology: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Teladoc Health, Inc. $2.47bn -2.4% -1.5%
Veeva Systems Inc $3.46bn 16.5% 15.7%
Tempus AI, Inc. $1.51bn 36.6% —
Waystar Holding Corp. $1.26bn 21.4% —
Omnicell, Inc. $1.25bn 8.5% 0.3%
Goodrx Holdings, Inc. $785m -1.8% 1.8%

Compare with peers

Head to head: TDOC vs VEEVTDOC vs TEMTDOC vs WAY

More: Health Care Technology stocks compared, Health Care sector, rankings of US companies

Figures from Teladoc Health, Inc.'s SEC filings (10-K and 10-Q), retrieved October 30, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Teladoc Health, Inc.